SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Abbruzzese A. 1988. Developmental pattern for deoxyhypusine hydroxylase in rat brain. J Neurochem 50: 695699.
  • Abbruzzese A, Park MH, Folk JE. 1986. Deoxyhypusine hydroxylase from rat testis. Partial purification and characterization. J Biol Chem 261: 30853089.
  • Abbruzzese A, Park MH, Beninati S, Folk JE. 1989. Inhibition of deoxyhypusine hydroxylase by polyamines and by a deoxyhypusine peptide. Biochem Biophys Acta 997: 248255.
  • Adams J. 2003. The proteasome: Structure, function, and role in the cell. Cancer Treat Rev 29: 39.
  • Arora T, Floyd-Smith G, Espy MJ, Jelinek DF. 1999. Dissociation between IFN-alpha-induced anti-viral and growth signalling pathways. J Immunol 162: 32893297.
  • Austin KJ, Ward SK, Teixeira MG, Dean VC, Moore DW, Hansen TR. 1996. Ubiquitin cross-reactive protein is released by the bovine uterus in response to interferon during early pregnancy. Biol Reprod 54: 600606.
  • Barahmand-pour F, Meinke A, Eilers A, Gouilleux F, Groner B, Decker T. 1995. Colony-stimulating factors and interferon-gamma activate a protein related to MGF-Stat 5 to cause formation of the differentiation-induced factor in myeloid cells. FEBS Lett 360: 2933.
  • Bazan JF. 1990a. Shared architecture of hormone binding domains in type I and II interferon receptors. Cell 61: 753754.
  • Bazan JF. 1990b. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87: 69346938.
  • Beadling C, Guschin D, Witthuhn BA, Ziemiecki A, Ihle JN, Kerr IM, Cantrell DA. 1994. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes. EMBO J 13: 56055615.
  • Beninati S, Gentile V, Caraglia M, Lentini A, Tagliaferri P, Abbruzzese A. 1998. Tissue transglutaminase expression affects hypusine metabolism in BALB/c 3T3 cells. FEBS Lett 437: 3438.
  • Brinckmann A, Axer S, Jakschies D, Dallmann I, Grosse J, Patzelt T, Bernier T, Emmendoerffer A, Atzpodien J. 2002. Interferon-alpha resistance in renal carcinoma cells is associated with defective induction of signal transducer and activator of transcription 1 which can be restored by a supernatant of phorbol 12-myristate 13-acetate stimulated peripheral blood mononuclear cells. Br J Cancer 86: 449455.
  • Bromberg JF. 2001. Activation of STAT proteins and growth control. Bioassays 23: 161169.
  • Bromberg JF, Horvath CM, Besser D, Lathem WW, Darnell JE Jr. 1998. Stat3 activation is required for cellular transformation by v-src. Mol Cell Biol 18: 25532558.
  • Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME. 1999. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96: 857868.
  • Budillon A, Tagliaferri P, Caraglia M, Torrisi MR, Normanno N, Iacobelli S, Palmieri G, Stoppelli MP, Frati L, Bianco AR. 1991. Upregulation of epidermal growth factor receptor induced by alpha-interferon in human epidermoid cancer cells. Cancer Res 51: 12941299.
  • Budillon A, Di Gennaro E, Caraglia M, Barbarulo D, Abbruzzese A, Tagliaferri P. 1999. 8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor. Br J Cancer 81: 11341141.
  • Buechner SA, Wernli M, Harr T, Hahn S, Itin P, Erb P. 1997. Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide. J Clin Investig 100: 26912696.
  • Burgering BMT, Coffer PJ. 1995. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376: 599602.
  • Cai J, Jones DP. 1998. Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss. J Biol Chem 273: 1140111404.
  • Caraglia M, Tagliaferri P, Correale P, Genua G, Pepe S, Pinto A, Del Vecchio S, Esposito G, Bianco AR. 1993. Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAb. Cancer Immunol Immunother 37: 150156.
  • Caraglia M, Pinto A, Correale P, Zagonel V, Genua G, Leardi A, Pepe S, Bianco AR, Tagliaferri P. 1994. 5-Aza-2′-deoxycytidine induces growth inhibition and upregulation of epidermal growth factor receptor on human epithelial cancer cells. Ann Oncol 5: 269276.
  • Caraglia M, Leardi A, Corradino S, Ciardiello F, Budillon A, Guarrasi R, Bianco AR, Tagliaferri P. 1995. alpha-interferon potentiates epidermal growth factor receptor-mediated effects on human epidermoid carcinoma KB cells. Int J Cancer 61: 342347.
  • Caraglia M, Passeggio A, Beninati S, Leardi A, Nicolini L, Improta S, Pinto A, Bianco AR, Tagliaferri P, Abbruzzese A. 1997. Interferon alpha2 recombinant and epidermal growth factor modulate proliferation and hypusine synthesis in human epidermoid cancer KB cells. Biochem J 324: 737741.
  • Caraglia M, Abbruzzese A, Leardi A, Pepe S, Budillon A, Baldassarre G, Selleri C, De Lorenzo S, Fabbrocini A, Giuberti G, Vitale G, Lupoli G, Bianco AR, Tagliaferri P. 1999. Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor. Cell Death Differ 6: 773780.
  • Caraglia M, Budillon A, Vitale G, Lupoli G, Tagliaferri P, Abbruzzese A. 2000. Modulation of molecular mechanisms involved in protein synthesis machinery as a new tool for the control of cell proliferation. Eur J Biochem 267: 39193936.
  • Caraglia M, Marra M, Giuberti G, D'Alessandro AM, Tassone P, Venuta S, Tagliaferri P, Abbruzzese A. 2003a. The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-alpha and EGF in human cancer cells. J Biochem 133: 757765.
  • Caraglia M, Tagliaferri P, Marra M, Giuberti G, Budillon A, Di Gennaro E, Pepe S, Vitale G, Improta S, Tassone PF, Venuta S, Bianco AR, Abbruzzese A. 2003b. EGF activates an inducible survival response via the RAS[RIGHTWARDS ARROW]Erk-1/2 pathway to counteract interferon-alpha-mediated apoptosis in epidermoid cancer cells. Cell Death Differ 10: 218229.
  • Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC. 1998. Regulation of cell death protease caspase-9 by phosphorylation. Science 282: 13181321.
  • Chawla-Sarkar M, Leaman DW, Borden EC. 2001. Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: Correlation with TRAIL/Apo2L induction in melanoma cell lines. Clin Cancer Res 7: 18211831.
  • Colamonici OR, Uyttendaele H, Domanski P, Yan H, Krolewski JJ. 1994a. p135tyk2, an interferon-alpha-activated tyrosine kinase, is physically associated with an interferon-alpha receptor. J Biol Chem 269: 35183522.
  • Colamonici OR, Yan H, Domanski P, Handa R, Smalley D, Mullersman J, Witte M, Krishnan K, Krolewski JJ. 1994b. Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase. Mol Cell Biol 14: 81338142.
  • Constantinescu SN, Croze E, Wang C, Murti A, Basu L, Mullersman JE, Pfeffer LM. 1994. Role of interferon alpha/beta receptor chain 1 in the structure and transmembrane signaling of the interferon alpha/beta receptor complex. Proc Natl Acad Sci USA 91: 96029606.
  • Copeland NG, Gilbert DJ, Schindler C, Zhong Z, Wen Z, Darnell JE Jr, Mui AL, Miyajima A, Quelle FW, Ihle JN. 1995. Distribution of the mammalian Stat gene family in mouse chromosomes. Genomics 29: 225228.
  • Dai C, Krantz SB. 1999. Interferon gamma induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells. Blood 93: 33093316.
  • Darnell JE Jr. 1997. STATs and gene regulation. Science 277: 16301635.
  • Darnell JE, Kerr IM, Stark GR. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 14151421.
  • Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231241.
  • David M, Petricoin E 3rd, Benjamin C, Pine R, Weber MJ, Larner AC. 1995. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. Science 269: 17211723.
  • Duncan SA, Zhong Z, Wen Z, Darnell JE. 1997. STAT signaling is active during early mammalian development. Dev Dyn 208: 190198.
  • Durbin JE, Hackenmiller R, Simon MC, Levy DE. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84: 443450.
  • Eilers A, Baccarini M, Hipskind RA, Schindler C, Decker T. 1994. A factor induced by differentiation signals in cells of the macrophage lineage binds to the gamma interferon activation site. Mol Cell Biol 14: 13641373.
  • Esposito C, Marra M, Giuberti G, D'Alessandro AM, Porta R, Cozzolino A, Caraglia M, Abbruzzese A. 2003. Ubiquitination of tissue transglutaminase is modulated by interferon alpha in human lung cancer cells. Biochem J 370: 205212.
  • Facchiano AM, Stiuso P, Chiusano ML, Caraglia M, Giuberti G, Marra M, Abbruzzese A, Colonna G. 2001. Homology modelling of the human eukaryotic initiation factor 5A (eIF-5A). Protein Eng 14: 881890.
  • Feldman GM, Rosenthal LA, Liu X, Hayes MP, Wynshaw-Boris A, Leonard WJ, Hennighausen L, Finbloom DS. 1997. STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. Blood 90: 17681776.
  • Fish EN, Uddin S, Korkmaz M, Majchrzak B, Druker BJ, Platanias LC. 1999. Activation of a CrkL-stat5 signaling complex by type I interferons. J Biol Chem 274: 571573.
  • Franke TF, Yang S-I, Chan TO, Datta K, Kazlaukas A, Morrison DK, Kaplan DR, Tsichlis PN. 1995. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81: 727736.
  • Franke TF, Kaplan DR, Cantley LC. 1997. PI3K: Downstream AKTion blocks apoptosis. Cell 88: 435437.
  • Fu XY. 1992. A transcription factor with SH2 and SH3 domains is directly activated by an interferon alpha-induced cytoplasmic protein tyrosine kinase(s). Cell 70: 323335.
  • Gil J, Esteban M. 2000. Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): Mechanism of action. Apoptosis 5: 107114.
  • Goh KC, Haque SJ, Williams BRG. 1999. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO J 18: 56015609.
  • Grumbach IM, Mayer IA, Uddin S, Lekmine F, Majchrzak B, Yamauchi H, Fujita S, Druker B, Fish EN, Platanias LC. 2001. Engagement of the CrkL adaptor in interferon alpha signalling in BCR-ABL-expressing cells. Br J Haematol 112: 327336.
  • Gupta S, Yan H, Wong LH, Ralph S, Krolewski J, Schindler C. 1996. The SH2 domains of Stat1 and Stat2 mediate multiple interactions in the transduction of IFN-alpha signals. EMBO J 15: 10751084.
  • Haan S, Hemmann U, Hassiepen U, Schaper F, Schneider-Mergener J, Wollmer A, Heinrich PC, Grotzinger J. 1999. Characterization and binding specificity of the monomeric STAT3-SH2 domain. J Biol Chem 274: 13421348.
  • Harvat BL, Jetten AM, Seth P. 1997. The role of p27Kip1 in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cells. Oncogene 14: 21112122.
  • Heim MH, Kerr IM, Stark GR, Darnell JE Jr. 1995. Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway. Science 267: 13471349.
  • Hershey JWB. 1991. Translational control in mammalian cells. Annu Rev Biochem 61: 717755.
  • Hoey T, Schindler U. 1998. STAT structure and function in signaling. Curr Opin Genet Dev 8: 582587.
  • Horvath CM, Darnell JE. 1997. The state of the STATs: Recent developments in the study of signal transduction to the nucleus. Curr Opin Cell Biol 9: 233239.
  • Horvath CM, Wen Z, Darnell JE. 1995. A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev 9: 984994.
  • Ihle JN. 1996. STATs: Signal transducers and activators of transcription. Cell 84: 331334.
  • Imada K, Leonard WJ. 2000. The Jak-STAT pathway. Mol Immunol 37: 111.
  • Jackson DP, Watling D, Rogers NC, Banks RE, Kerr IM, Selby PJ, Patel PM. 2003. The JAK/STAT pathway is not sufficient to sustain the antiproliferative response in an interferon-resistant human melanoma cell line. Melanoma Res 13: 219229.
  • Jan MS, Liu HS, Lin YS. 1999. Bad overexpression sensitizes NIH/3T3 cells to undergo apoptosis which involves caspase activation and ERK inactivation. Biochem Biophys Res Commun 264: 724729.
  • Kaplan MH, Schindler U, Smiley ST, Gruspy MJ. 1996. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4: 313319.
  • Kaplan MH, Sun Y-L, Hoey T, Grusby MJ. 1996. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382: 174177.
  • Kim H, Baumann H. 1997. The carboxyl-terminal region of STAT3 controls gene induction by the mouse haptoglobin promoter. J Biol Chem 272: 1457114579.
  • Kotenko SV, Pestka S. 2000. Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes. Oncogene 19: 25572565.
  • Krammer PH. 2000. CD95's deadly mission in the immune system. Nature 407: 789795.
  • Landolfo S, Guarini A, Riera L, Gariglio M, Gribaudo G, Cignetti A, Cordone I, Montefusco E, Mandelli F, Foa R. 2000. Chronic myeloid leukemia cells resistant to interferon-alpha lack STAT1 expression. Hematol J 1: 714.
  • Larsen L, Ropke C. 2002. Suppressors of cytokine signalling: SOCS. APMIS 110: 833844.
  • Lee CH, Park MH. 2000. Human deoxyhypusine synthase: Interrelationship between binding of NAD and substrates. Biochem J 352: 851857.
  • Leonard WJ, O'Shea JJ. 1998. Jaks and STATs: Biological implications. Annu Rev Immunol 16: 293322.
  • Levy DE. 1999. Physiological significance of STAT proteins: Investigations through gene disruption in vivo. Cell Mol Life Sci 55: 15591567.
  • Lipowsky G, Bischoff FR, Schwarzmaier P, Kraft R, Kostka S, Hartmann E, Kutay U, Gorlich D. 2000. Exportin 4: A mediator of a novel nuclear export pathway in higher eukaryotes. EMBO J 19: 43624371.
  • Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L. 1997. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev 11: 179186.
  • Los M, Herr I, Friesen C, Fulda S, Schulze-Osthoff K, Debatin KM. 1997. Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases). Blood 90: 31183129.
  • Lund TC, Medveczky MM, Medveczky PG. 1999. Interferon-alpha induction of STATs1, -3 DNA binding and growth arrest is independent of Lck and active mitogen-activated kinase in T cells. Cell Immunol 192: 133139.
  • Matsui W, Huff CA, Vala M, Barber J, Smith BD, Jones RJ. 2003. Anti-tumour activity of interferon-alpha in multiple myeloma: Role of interleukin 6 and tumor cell differentiation. Br J Haematol 121: 251258.
  • Mayer IA, Verma A, Grumbach IM, Uddin S, Lekmine F, Ravandi F, Majchrzak B, Fujita S, Fish EN, Platanias LC. 2001. The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cells. J Biol Chem 276: 2857028577.
  • Meinke A, Barahmand-Pour F, Wohrl S, Stoiber D, Decker T. 1996. Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons. Mol Cell Biol 16: 69376945.
  • Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84: 431442.
  • Moriggl R, Berchtold S, Friedrich K, Standke GJ, Kammer W, Heim M, Wissler M, Stocklin E, Gouilleux F, Groner B. 1997. Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells. Mol Cell Biol 17: 36633678.
  • Mullersman JE, Pfeffer LM. 1994. Role of interferon alpha/beta receptor chain 1 in the structure and transmembrane signaling of the interferon alpha/beta receptor complex. Trends Biochem Sci 20: 5556.
  • Navarro A, Anand-Apte B, Tanabe Y, Feldman G, Larner AC. 2003. A PI-3 kinase-dependent, Stat1-independent signaling pathway regulates interferon-stimulated monocyte adhesion. J Leukoc Biol 73: 540545.
  • Nyman TA, Matikainen S, Sareneva T, Julkunen I, Kalkkinen N. 2000. Proteome analysis reveals ubiquitin-conjugating enzymes to be a new family of interferon-alpha-regulated genes. Eur J Biochem 267: 40114019.
  • Panaretakis T, Pokrovskaja K, Shoshan MC, Grandèr D. 2003. Interferon-alpha-induced apoptosis in U266 cells is associated with activation of the proapoptotic Bcl-2 family members Bak and Bax. Oncogene 22: 45434556.
  • Park MH, Wolff EC, Smit-McBride Z, Hershey JWB, Folk JE. 1991. Comparison of the activities of variant forms of eIF-4D. The requirement for hypusine or deoxyhypusine. J Biol Chem 266: 79887994.
  • Park MH, Wolff EC, Folk JE. 1993. Hypusine: Its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation. BioFactors 4: 95104.
  • Pestka S. 1981a. Cloning of the human interferons. Methods Enzymol 78: 1632.
  • Pestka S. 1981b. Interferons. Part B. Introduction. Methods Enzymol 79: 1677.
  • Pestka S. 1986. Interferon from 1981 to 1986. Methods Enzymol 119: 1845.
  • Pestka S. 2000. The human interferon alpha species and receptors. Biopolymers (Peptide Sci) 55: 254287.
  • Pestka S, Langer JA, Zoon KC, Samuel CE. 1987. Interferons and their actions. Ann Rev Biochem 56: 727777.
  • Pfeffer LM, Mullersman JE, Pfeffer SR, Murti A, Shi W, Yang CH. 1997. STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor. Science 276: 14181420.
  • Puthier D, Thabard W, Rapp M, Etrillard M, Harousseau J, Bataille R, Amiot M. 2001. Interferon alpha extends the survival of human myeloma cells through an upregulation of the Mcl-1 anti-apoptotic molecule. Br J Haematol 112: 358363.
  • Ransohoff RM. 1998. Cellular responses to interferons and other cytokines: The JAK-STAT paradigm. N Engl J Med 338: 616618.
  • Raza A. 2000. Consilience across evolving dysplasias affecting myeloid, cervical, esophageal, gastric, and liver cells: Common themes and emerging patterns. Leuk Res 24: 6372.
  • Romerio F, Zella D. 2002. MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b. FASEB J 16: 16801682.
  • Romerio F, Riva A, Zella D. 2000. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism. Br J Cancer 83: 532538.
  • Roth W, Wagenknecht B, Dichgans J, Weller M. 1998. Interferon-alpha enhances CD95L-induced apoptosis of human malignant glioma cells. J Neuroimmunol 87: 121129.
  • Sadowski HB, Shuai K, Darnell JE Jr, Gilman MZ. 1993. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 261: 17391744.
  • Sanceau J, Hiscott J, Delattre O, Wietzerbin J. 2000. IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7. Oncogene 19: 33723383.
  • Sangfelt O, Erickson S, Castro J, Heiden T, Einhorn S, Grander D. 1997. Induction of apoptosis and inhibition of cell growth are independent responses to interferon-alpha in hematopoietic cell lines. Cell Growth Differ 8: 343352.
  • Schindler C, Darnell JE Jr. 1995. Transcriptional responses to polypeptide ligands: The JAK-STAT pathway. Annu Rev Biochem 64: 621651.
  • Schindler CW, Shuai K, Prezioso VR, Darnell JE Jr. 1992. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257: 809813.
  • Schindler U, Wu P, Rothe M, Brasseur M, Mc-Knight SL. 1995. Components of a Stat recognition code: Evidence for two layers of molecular selectivity. Immunity 2: 689697.
  • Shigeno M, Nakao K, Ichikawa T, Suzuki K, Kawakami A, Abiru S, Miyazoe S, Nakagawa Y, Ishikawa H, Hamasaki H, Nakata K, Ishii N, Eguchi K. 2003. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation. Oncogene 22: 16531662.
  • Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, Chu C, Quelle FW, Nosaka T, Vignali DA, Doherty PC, Grosveld G, Paul WE, Ihle JN. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380: 630633.
  • Shnier J, Schwelberger H, Smit-McBride Z, Kang HA, Hershey JWB. 1991. Translation initiation factor 5A and its hypusine modification are essential for cell viability in the yeast Saccharomyces cerevisiae. Mol Cell Biol 11: 31053114.
  • Shuai K, Stark GR, Kerr IM, Darnell JE Jr. 1993a A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science 261: 17441746.
  • Shuai K, Ziemiecki A, Wilks AF, Harpur AG, Sadowski HB, Gilman MZ, Darnell JE. 1993b. Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature 366: 580583.
  • Shuai K, Horvath CM, Huang LHT, Qureshi SA, Cowburn D, Darnell JE Jr. 1994. Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell 76: 821828.
  • Spets H, Georgii-Hemming P, Siljason J, Nilsson K, Jernberg-Wiklund H. 1998. Fas/APO-1 (CD95)-mediated apoptosis is activated by interferon-gamma and interferon- in interleukin-6 (IL-6)-dependent and IL-6-independent multiple myeloma cell lines. Blood 92: 29142923.
  • Steiner T, Junker U, Henzgen B, Nuske K, Durum SK, Schubert J. 2001. Interferon-alpha suppresses the antiapoptotic effect of NF-κB and sensitizes renal cell carcinoma cells in vitro to chemotherapeutic drugs. Eur Urol 39: 478483.
  • Tagliaferri P, Caraglia M, Muraro R, Budillon A, Pinto A, Bianco AR. 1994. Pharmacological modulation of peptide growth factor receptor expression on tumor cells as a basis for cancer therapy. Anti-Cancer Drugs 5: 379393.
  • Takaoka A, Hayakawa S, Yanai H, Stoiber D, Negishi H, Kikuchi H, Sasaki S, Imai K, Shibue T, Honda K, Taniguchi T. 2003. Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 424: 516523.
  • Takeda K, Akira S. 2000. STAT family of transcription factors in cytokine-mediated biological responses. Cytokine Growth Factor Rev 11: 199207.
  • Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, Kishimoto T, Akira S. 1997. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA 94: 38013804.
  • Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DA, Doherty PC, Grosveld GC, Ihle JN. 1996. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382: 171174.
  • Thoreau E, Petridou B, Kelly PA, Djiane J, Mornon JB. 1991. Structural symmetry of the extracellular domain of the cytokine/growth hormone/prolactin receptor family and interferon receptors revealed by hydrophobic cluster analysis. FEBS Lett 282: 2631.
  • Thyrell L, Erickson S, Zhivotovsky B, Pokrovskaja K, Sangfelt O, Castro J, Einhorn S, Grander D. 2002. Mechanisms of interferon-alpha induced apoptosis in malignant cells. Oncogene 21: 12511262.
  • Tian Z, Shen X, Feng H, Gao B. 2000. IL-1 beta attenuates IFN-alpha beta-induced antiviral activity and STAT1 activation in the liver: Involvement of proteasome-dependent pathway. J Immunol 165: 39593965.
  • Tracey L, Villuendas R, Ortiz P, Dopazo A, Spiteri I, Lombardia L, Rodriguez-Peralto JL, Fernandez-Herrera J, Hernandez A, Fraga J, Dominguez O, Herrero J, Alonso MA, Dopazo J, Piris MA. 2002. Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. Am J Pathol 161: 18251837.
  • Turkson J, Bowman T, Adnane J, Zhang Y, Djeu JY, Sekharam M, Frank DA, Holzman LB, Wu J, Sebti S, Jove R. 1999. Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. Mol Cell Biol 19: 75197528.
  • Uddin S, Majchrzak B, Woodson J, Arunkumar P, Alsayed Y, Pine R, Young PR, Fish EN, Platanias LC. 1999. Activation of the p38 mitogen-activated protein kinase by type I interferons. J Biol Chem 274: 3012730131.
  • Uddin S, Lekmine F, Sharma N, Majchrzak B, Mayer I, Young PR, Bokoch GM, Fish EN, Platanias LC. 2000. The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteins. J Biol Chem 275: 2763427640.
  • Uddin S, Sassano A, Deb DK, Verma A, Majchrzak B, Rahman A, Malik AB, Fish EN, Platanias LC. 2002. Protein kinase C-delta (PKC-delta) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J Biol Chem 277: 1440814416.
  • Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ, Davey HW. 1997. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA 94: 72397244.
  • Ulane CM, Rodriguez JJ, Parisien JP, Horvath CM. 2003. STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling. J Virol 77: 63856393.
  • Verma A, Deb DK, Sassano A, Uddin S, Varga G, Wickrema A, Platanias LC. 2002. Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis. J Biol Chem 277: 77267735.
  • Vinkemeier U, Cohen SL, Moarefi I, Chait BT, Kuriyan J, Darnell JE Jr. 1996. DNA binding of in vitro activated Stat1 alpha, Stat1 beta, and truncated Stat1: Interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites. EMBO J 15: 56165626.
  • Wen Z, Zhong Z, Darnell JE Jr. 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82: 241250.
  • Williams JG. 2000. STAT signalling in cell proliferation and in development. Curr Opin Genet Dev 10: 503507.
  • Wolff EC, Park MH, Folk JE. 1990. Cleavage of spermidine as the first step in deoxyhypusine synthesis. The role of NAD. J Biol Chem 265: 47934799.
  • Wong LH, Krauer KG, Hatzinisiriou I, Estcourt MJ, Hersey P, Tam ND, Edmondson S, Devenish RJ, Ralph SJ. 1997. Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma. J Biol Chem 272: 2877928785.
  • Xu X, Sun YL, Hoey T. 1996. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science 273: 794797.
  • Yamauchi H, Sakai I, Narumi H, Takeuchi K, Soga S, Fujita S. 2001. Development of interferon-alpha resistant subline from human chronic myelogenous leukemia cell line KT-1. Intern Med 40: 607612.
  • Yan H, Krishnan K, Lim JTE, Contillo LG, Krolewski JJ. 1996a. Molecular characterization of an alpha interferon receptor 1 subunit (IFNαR1) domain required for TYK2 binding and signal transduction. Mol Cell Biol 16: 20742082.
  • Yan H, Krishnan K, Greenlund AC, Gupta S, Lim JTE, Schreiber RD, Schindler CW, Krolewski JJ. 1996b. Phosphorylated interferon-alpha receptor 1 subunit (IFNαR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein. EMBO J 15: 10641074.
  • Yang CH, Murti A, Pfeffer LM. 1998. STAT3 complements defects in an interferon-resistant cell line: Evidence for an essential role for STAT3 in interferon signaling and biological activities. Proc Natl Acad Sci USA 95: 55685572.
  • Yang CH, Murti A, Pfeffer SR, Kim JG, Donner DB, Pfeffer LM. 2001. Interferon alpha /beta promotes cell survival by activating nuclear factor kappa B through phosphatidylinositol 3-kinase and Akt. J Biol Chem 17: 1375613761.
  • Zhang X, Blenis J, Li HC, Schindler C, Chen-Kiang S. 1995. Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 267: 19901994.